Concepedia

Yanni Zhu

YZ

35

Publications

4.7K

Citations

24

H-Index

2009

Active since

Affiliations

Gilead Sciences (United States)(Current)

Harvard University

Massachusetts General Hospital

University of California, Los Angeles

Emory University

Yanni Zhu is an author at Gilead Sciences (United States) specializing in medicine, cell biology, and radiation oncology.

Top concepts

Publications per year

2009–2024

35

Publications

35

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

Nezam H. Afdhal, K. Rajender Reddy, David R. Nelson et al. · New England Journal of Medicine · 2014 · 1.3K citations

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

Jordan J. Feld, Ira M. Jacobson, Christophe Hézode et al. · New England Journal of Medicine · 2015 · 1.1K citations · Full text

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

, , +9

Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

Ira M. Jacobson, Eric Lawitz, Edward Gane et al. · Gastroenterology · 2017 · 236 citations · Full text

, , +10

The safety and effectiveness of ledipasvir−sofosbuvir in adolescents 12‐17 years old with hepatitis C virus genotype 1 infection

William F. Balistreri, Karen F. Murray, Philip Rosenthal et al. · Hepatology · 2016 · 195 citations · Full text

Rows per page

1–5 of 35